These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 32387864)

  • 41. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Filardi T; Morano S
    J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there an association between oral health and severity of COVID-19 complications?
    Botros N; Iyer P; Ojcius DM
    Biomed J; 2020 Aug; 43(4):325-327. PubMed ID: 32713780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Putative Roles for Peptidylarginine Deiminases in COVID-19.
    Arisan ED; Uysal-Onganer P; Lange S
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Novel Coronavirus Outbreak: What We Know and What We Don't.
    Cell; 2020 Mar; 180(6):1034-1036. PubMed ID: 32078801
    [No Abstract]   [Full Text] [Related]  

  • 45. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity and COVID-19: The Two Sides of the Coin.
    Dicker D; Bettini S; Farpour-Lambert N; Frühbeck G; Golan R; Goossens G; Halford J; O'Malley G; Mullerova D; Ramos Salas X; Hassapiou MN; Sagen J; Woodward E; Yumuk V; Busetto L
    Obes Facts; 2020; 13(4):430-438. PubMed ID: 32659766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
    Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
    J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
    Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience.
    Caraffa R; Bagozzi L; Fiocco A; Bifulco O; Nadali M; Ponzoni M; Carrozzini M; Toscano G; Fraiese AP; Metra M; Lombardi CM; Serafini F; Ribola A; Jorgji V; Bottio T; Gerosa G
    Eur J Cardiothorac Surg; 2020 Nov; 58(5):899-906. PubMed ID: 33084868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obesity in Mexico: rapid epidemiological transition and food industry interference in health policies.
    Barquera S; Rivera JA
    Lancet Diabetes Endocrinol; 2020 Sep; 8(9):746-747. PubMed ID: 32822599
    [No Abstract]   [Full Text] [Related]  

  • 51. Critical role of laboratory medicine in the global response to the COVID-19 pandemic.
    Adeli K
    Clin Chem Lab Med; 2020 Jun; 58(7):1019-1020. PubMed ID: 32484451
    [No Abstract]   [Full Text] [Related]  

  • 52. The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review.
    Al-Sadeq DW; Nasrallah GK
    Int J Infect Dis; 2020 Sep; 98():372-380. PubMed ID: 32623083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 and obesity.
    Finer N; Garnett SP; Bruun JM
    Clin Obes; 2020 Jun; 10(3):e12365. PubMed ID: 32342637
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily.
    Gavriilaki E; Brodsky RA
    Br J Haematol; 2020 Jun; 189(6):e227-e230. PubMed ID: 32369610
    [No Abstract]   [Full Text] [Related]  

  • 56. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.
    Zhao Y; Zhao Z; Wang Y; Zhou Y; Ma Y; Zuo W
    Am J Respir Crit Care Med; 2020 Sep; 202(5):756-759. PubMed ID: 32663409
    [No Abstract]   [Full Text] [Related]  

  • 58. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions.
    Kruglikov IL; Shah M; Scherer PE
    Elife; 2020 Sep; 9():. PubMed ID: 32930095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
    Ciaccio M; Agnello L
    Diagnosis (Berl); 2020 Nov; 7(4):365-372. PubMed ID: 32589600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.